Comparison of mitoxantrone-melphalan and BEAM conditioning regimens in patients with lymphoma.
Sign Up to like & getrecommendations! Published in 2021 at "Hematology/oncology and stem cell therapy"
DOI: 10.1016/j.hemonc.2021.03.005
Abstract: OBJECTIVE/BACKGROUND Lymphoma is seen as a highly treatable and curable malignancy with aggressive treatment methods. Efficacy is often limited by toxicity and many patients need alternative treatment strategies as they cannot tolerate existing high cytotoxic… read more here.
Keywords: patients lymphoma; mel regimen; melphalan; mitoxantrone melphalan ... See more keywords